News
The Maharashtra Authority for Advance Ruling (AAR) has determined that the cancer prognostic and diagnostic services provided ...
Market’s Robust Growth Driven by Rising Demand for Contamination-Free Sampling in Biotechnology and Pharmaceutical Industries ...
The resurrected Rosalind Franklin composite rover mission’s key systems will be upgraded with support from the TAS, ESA and ...
Discover how BioPure's BioClamp reduces emissions and enhances bioprocessing. Read more on our sustainable solutions.
BioPure, a leading provider of single-use fluid path components and connectors since 1998, has advanced the manufacturing of BioClamp to bring sustainability benefits to usersBioClamp is manufactured ...
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...
On June 5, 2024, two experienced NASA astronauts went to the International Space Station (ISS) for an eight-day test flight. But things didn’t go as planned. A series of unexpected problems left ...
In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...
March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results